- Security of Chinese nationals working in Pakistan remains govt's top priority, premier says
July 17, 2026
ISLAMABAD: Prime Minister Muhammad Shehbaz Sharif witnesses the signing and exchange of agreements between Chinese and Pakistani pharmaceutical companies at the Pak China Pharmaceutical B2B Conference on 17 July 2026. - Photo: PMO
APP
BRecorder
Prime Minister Shehbaz Sharif on Friday hailed the signing of nine agreements worth around $440 million between Pakistani and Chinese private enterprises in the pharmaceutical sector, describing the development as a major step towards strengthening bilateral economic cooperation and advancing the next phase of the China-Pakistan Economic Corridor (CPEC 2.0).
Addressing the Pakistan-China Pharmaceutical Business-to-Business Conference in Islamabad, the prime minister expressed confidence that the agreements would turn into practical projects, saying they would boost investment in pharmaceutical manufacturing, vaccines, research and development, and help Pakistan emerge as a regional centre for the production and export of life-saving medicines.
“I think this will ultimately result into manufacturing life saving medicines, vaccines, research and development and become a center of excellence for exporting our wonderful products to neighboring countries,” he said.
He said China had consistently stood by Pakistan during difficult times and had already invested more than $30 billion under first phase of CPEC, calling the new partnerships another milestone in expanding economic cooperation.